News
Ahead of their graduation earlier this month, two Lake Forest High School students received national recognition for the ...
U.S. pharmaceutical firms are ramping up licensing deals with Chinese biotech companies, aiming to fill pipelines as major drug patents near expiration.
Discover how U.S. biotechs can learn from China's success in affordable, high-quality drug development. Read more here.
During the Covid-19 pandemic, South African and Colombian civil society organisations initiated strategic litigation against their governments to gain transparency on confidential vaccine contracts ...
Residents living near Port of Cork are in for a surprise this Friday, as a loud warning siren is set to blare across ...
After months of waking up with headaches, Claire visited her GP. Her life was turned upside down as doctors discovered what ...
7h
Zacks Investment Research on MSNPFE or LLY: Which Is the Better Value Stock Right Now?Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Eli Lilly (LLY). But which of these two stocks is more attractive to value ...
10hOpinion
Zacks Investment Research on MSN5 Large Drug Stocks That Are Poised to Ride on Sector RecoveryThe sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...
Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...
The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results